Nikotiinireseptorit (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nikotiinireseptorit" in Finnish language version.

refsWebsite

Global rank Finnish rank

28nih.gov

4^th place

12^th place

17doi.org

2^nd place

10^th place

17worldcat.org

5^th place

9^th place

2sciencedirect.com

149^th place

237^th place

1biomedcentral.com

2,747^th place

1,855^th place

1oup.com

485^th place

642^nd place

1genenames.org

low place

1nature.com

234^th place

201^st place

biomedcentral.com

bmcgenomics.biomedcentral.com

Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848 doi:10.1186/s12864-019-6278-9 ISSN 1471-2164 Artikkelin verkkoversio.

doi.org

dx.doi.org

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755 doi:10.1152/physrev.00015.2008 ISSN 0031-9333 Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137 doi:10.1074/jbc.M115.646786 ISSN 0021-9258 Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313 doi:10.1146/annurev.pharmtox.48.113006.094742 ISSN 0362-1642 Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248 doi:10.1186/s12862-018-1341-8 ISSN 1471-2148 Artikkelin verkkoversio.
Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848 doi:10.1186/s12864-019-6278-9 ISSN 1471-2164 Artikkelin verkkoversio.
RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452 doi:10.1093/toxsci/kfs118 ISSN 1096-6080 Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968 doi:10.1371/journal.ppat.1008715 ISSN 1553-7366 Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538 doi:10.1371/journal.pone.0079653 ISSN 1932-6203 Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712 doi:10.1038/s41467-019-10723-x ISSN 2041-1723 Artikkelin verkkoversio.
CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925 doi:10.1038/gim.2014.9 ISSN 1530-0366 Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020 doi:10.1016/j.apsb.2017.09.001 ISSN 2211-3835 Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327 doi:10.3389/fnsyn.2020.607959 ISSN 1663-3563 Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338 doi:10.1124/pr.119.018028 ISSN 0031-6997 Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444 doi:10.1124/mol.119.118786 ISSN 0026-895X Artikkelin verkkoversio.
HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645 doi:10.1016/j.bbamem.2014.11.003 ISSN 0006-3002 Artikkelin verkkoversio.
HG Campello: Unlocking nicotinic selectivity via direct C‒H functionalization of (−)-cytisine. Chem, 2018, 4. vsk, nro 7, s. 1710–1725. doi:10.1016/j.chempr.2018.05.007 ISSN 2451-9294 Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658 doi:10.1021/cn500369h ISSN 1948-7193 Artikkelin verkkoversio.

genenames.org

Gene group: Cholinergic receptors nicotinic subunits (CHRN) genenames.org. Viitattu 27.3.2021.

nature.com

CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925 doi:10.1038/gim.2014.9 ISSN 1530-0366 Artikkelin verkkoversio.

nih.gov

pubmed.ncbi.nlm.nih.gov

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755 doi:10.1152/physrev.00015.2008 ISSN 0031-9333 Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137 doi:10.1074/jbc.M115.646786 ISSN 0021-9258 Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313 doi:10.1146/annurev.pharmtox.48.113006.094742 ISSN 0362-1642 Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248 doi:10.1186/s12862-018-1341-8 ISSN 1471-2148 Artikkelin verkkoversio.
Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848 doi:10.1186/s12864-019-6278-9 ISSN 1471-2164 Artikkelin verkkoversio.
RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452 doi:10.1093/toxsci/kfs118 ISSN 1096-6080 Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968 doi:10.1371/journal.ppat.1008715 ISSN 1553-7366 Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538 doi:10.1371/journal.pone.0079653 ISSN 1932-6203 Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712 doi:10.1038/s41467-019-10723-x ISSN 2041-1723 Artikkelin verkkoversio.
CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925 doi:10.1038/gim.2014.9 ISSN 1530-0366 Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020 doi:10.1016/j.apsb.2017.09.001 ISSN 2211-3835 Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327 doi:10.3389/fnsyn.2020.607959 ISSN 1663-3563 Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338 doi:10.1124/pr.119.018028 ISSN 0031-6997 Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444 doi:10.1124/mol.119.118786 ISSN 0026-895X Artikkelin verkkoversio.
HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645 doi:10.1016/j.bbamem.2014.11.003 ISSN 0006-3002 Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658 doi:10.1021/cn500369h ISSN 1948-7193 Artikkelin verkkoversio.

ncbi.nlm.nih.gov

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755 doi:10.1152/physrev.00015.2008 ISSN 0031-9333 Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137 doi:10.1074/jbc.M115.646786 ISSN 0021-9258 Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313 doi:10.1146/annurev.pharmtox.48.113006.094742 ISSN 0362-1642 Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248 doi:10.1186/s12862-018-1341-8 ISSN 1471-2148 Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968 doi:10.1371/journal.ppat.1008715 ISSN 1553-7366 Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538 doi:10.1371/journal.pone.0079653 ISSN 1932-6203 Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712 doi:10.1038/s41467-019-10723-x ISSN 2041-1723 Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020 doi:10.1016/j.apsb.2017.09.001 ISSN 2211-3835 Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327 doi:10.3389/fnsyn.2020.607959 ISSN 1663-3563 Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338 doi:10.1124/pr.119.018028 ISSN 0031-6997 Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444 doi:10.1124/mol.119.118786 ISSN 0026-895X Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658 doi:10.1021/cn500369h ISSN 1948-7193 Artikkelin verkkoversio.

oup.com

academic.oup.com

RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452 doi:10.1093/toxsci/kfs118 ISSN 1096-6080 Artikkelin verkkoversio.

sciencedirect.com

HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645 doi:10.1016/j.bbamem.2014.11.003 ISSN 0006-3002 Artikkelin verkkoversio.
HG Campello: Unlocking nicotinic selectivity via direct C‒H functionalization of (−)-cytisine. Chem, 2018, 4. vsk, nro 7, s. 1710–1725. doi:10.1016/j.chempr.2018.05.007 ISSN 2451-9294 Artikkelin verkkoversio.

worldcat.org

EX Albuquerque et al: Mammalian nicotinic acetylcholine receptors: from structure to function. Physiological reviews, 2009, 89. vsk, nro 1, s. 73–120. PubMed:19126755 doi:10.1152/physrev.00015.2008 ISSN 0031-9333 Artikkelin verkkoversio.
J Wang et al: An accessory agonist binding site promotes activation of α4β2*nicotinic acetylcholine receptors. The Journal of Biological Chemistry, 2015, 290. vsk, nro 22, s. 13907–13918. PubMed:25869137 doi:10.1074/jbc.M115.646786 ISSN 0021-9258 Artikkelin verkkoversio.
NL Benowitz: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual review of pharmacology and toxicology, 2009, 49. vsk, s. 57–71. PubMed:18834313 doi:10.1146/annurev.pharmtox.48.113006.094742 ISSN 0362-1642 Artikkelin verkkoversio.
JE Pedersen, CA Bergqvist, D Larhammar: Evolution of vertebrate nicotinic acetylcholine receptors. BMC Evolutionary Biology, 2019, 19. vsk, nro 38. PubMed:30700248 doi:10.1186/s12862-018-1341-8 ISSN 1471-2148 Artikkelin verkkoversio.
Y Jiao et al: Massive expansion and diversity of nicotinic acetylcholine receptors in lophotrochozoans. BMC Genomics, 2019, 5. vsk, nro 1, s. 937. PubMed:31805848 doi:10.1186/s12864-019-6278-9 ISSN 1471-2164 Artikkelin verkkoversio.
RJ Rasoulpour et al: A novel mode-of-action mediated by the fetal muscle nicotinic acetylcholine receptor resulting in developmental toxicity in rats. Toxicological Sciences, 2012, 127. vsk, nro 2, s. 522–534. PubMed:22461452 doi:10.1093/toxsci/kfs118 ISSN 1096-6080 Artikkelin verkkoversio.
L Rufener et al: Nicotinic acetylcholine receptors: ex-vivo expression of functional, non-hybrid, heteropentameric receptors from a marine arthropod, Lepeophtheirus salmonis. PLoS Pathogens, 2020, 16. vsk, nro 7. PubMed:32716968 doi:10.1371/journal.ppat.1008715 ISSN 1553-7366 Artikkelin verkkoversio.
BG Campling, A Kuryatov, J Lindstrom: Acute activation, desensitization and smoldering activation of human acetylcholine receptors. PLoS ONE, 2013, 8. vsk, nro 11. PubMed:24244538 doi:10.1371/journal.pone.0079653 ISSN 1932-6203 Artikkelin verkkoversio.
GB Dawe et al: α7 nicotinic acetylcholine receptor upregulation by anti-apoptotic Bcl-2 proteins. Nature Communications, 2019, 10. vsk, nro 2746, s. 1–11. PubMed:31227712 doi:10.1038/s41467-019-10723-x ISSN 2041-1723 Artikkelin verkkoversio.
CP Schaaf: Nicotinic acetylcholine receptors in human genetic disease. Genetics in Medicine, 2014, 16. vsk, nro 9, s. 649–656. PubMed:24556925 doi:10.1038/gim.2014.9 ISSN 1530-0366 Artikkelin verkkoversio.
T Yang et al: The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials. Acta Pharmaceutica Sinica. B, 2017, 7. vsk, nro 6, s. 611–622. PubMed:29159020 doi:10.1016/j.apsb.2017.09.001 ISSN 2211-3835 Artikkelin verkkoversio.
P Scholze, S Huck: The α5 nicotinic acetylcholine receptor subunit differentially modulates α4β2* and α3β4* receptors. Frontiers in Synaptic Neuroscience, 2020, 12. vsk, nro 607959. PubMed:33343327 doi:10.3389/fnsyn.2020.607959 ISSN 1663-3563 Artikkelin verkkoversio.
MJ Moerke, LR McMahon, JL Wilkerson: More than smoke and patches: the quest for pharmacotherapies to treat tobacco use disorder. Pharmacological Reviews, 2020, 72. vsk, nro 2, s. 527–557. PubMed:32205338 doi:10.1124/pr.119.018028 ISSN 0031-6997 Artikkelin verkkoversio.
H Xing et al: A methyl scan of the pyrrolidinium ring of nicotine reveals significant differences in its interactions with α7 and α4β2 nicotinic acetylcholine receptors. Molecular Pharmacology, 2020, 98. vsk, nro 2, s. 168–180. PubMed:32474444 doi:10.1124/mol.119.118786 ISSN 0026-895X Artikkelin verkkoversio.
HR Arias et al: Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta, 2015, 1848. vsk, nro 2, s. 731–741. PubMed:25475645 doi:10.1016/j.bbamem.2014.11.003 ISSN 0006-3002 Artikkelin verkkoversio.
HG Campello: Unlocking nicotinic selectivity via direct C‒H functionalization of (−)-cytisine. Chem, 2018, 4. vsk, nro 7, s. 1710–1725. doi:10.1016/j.chempr.2018.05.007 ISSN 2451-9294 Artikkelin verkkoversio.
KL Price et al: Varenicline interactions at the 5-HT3 receptor ligand binding site are revealed by 5-HTBP. ACS Chemical Neuroscience, 2015, 6. vsk, nro 7, s. 1151–1157. PubMed:25648658 doi:10.1021/cn500369h ISSN 1948-7193 Artikkelin verkkoversio.